Targeted imaging of infection

Advanced Drug Delivery Reviews

Volumn 37, Issue 1-3, 1999, Pages 237-252

  Babich, John W ^a,b   Fischman, Alan J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Biostream Inc   (United States)

Author keywords

Agents; Infection; Inflammation; Targeting

Indexed keywords

BLOOD; CELLS; COMPUTERIZED TOMOGRAPHY; INDIUM; MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; MOLECULAR WEIGHT; NUCLEAR MEDICINE; PHYSIOLOGY; PROTEINS; TECHNETIUM; TISSUE;

BLOOD CLEARANCE; IMMUNOGLOBULINS; INFECTION IMAGING; INFLAMMATION; LEUKOCYTES; PATHOPHYSIOLOGY; TARGETING;

CONTROLLED DRUG DELIVERY;

CHEMOTACTIC PEPTIDE; GALLIUM CITRATE GA 67; IMMUNOGLOBULIN; LEUKOCYTE IN 111; MONOCLONAL ANTIBODY; PENTETIC ACID DERIVATIVE; POLYCLONAL ANTIBODY; TECHNETIUM 99M;

ANIMAL MODEL; BLOOD; DIAGNOSTIC IMAGING; DIFFUSION; DRUG DISTRIBUTION; DRUG TARGETING; FEVER; HUMAN; INFECTION; INFLAMMATION; ISOTOPE LABELING; MOLECULAR SIZE; MOLECULAR WEIGHT; NEUTROPENIA; NONHUMAN; PATHOPHYSIOLOGY; PLASMA CLEARANCE; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVIEW; TISSUE INJURY;

EID: 0344527885     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00096-9     Document Type: Review

References (103)

1. O.H. Arenholz, R.L. Simmons, Pancreatitis and other intraabdominal infections, in: H.R.J. Simmons (Ed.), Surgical Infectious Disease, 2nd ed., Appleton & Lang, Norwalk, CT, 1988, pp. 605-646.
2. P.A. Pizzo, Evaluation of fever in the patient with cancer, Eur. J. Cancer Clin. Oncol. Suppl 2 (1989) S9-S16.
3. J.P. Lavender, J. Lowe, J.R. Barker, J.I. Burn, M.A. Chaudri, Ga-67 citrate scanning in neoplastic and inflammatory disease, Br. J. Radiol. 44 (1971) 361-366.
4. D.C. Blair, M. Carroll, J. Silva, F.R. Fekety Jr., Localization of infectious processes with gallium citrate Ga 67, J. Am. Med. Assoc. 230 (1) (1974) 82-85.
5. J.W. Froelich, D. Swanson, Imaging of inflammatory processes with labeled cells, Semin. Nucl. Med. 14 (1984) 128-140.
6. A.M. Peters, S.H. Saverymuttu, H.J. Reavy, H.J. Danpure, S. Osman, J.P. Lavender, Imaging of inflammation with indium-111 tropolonate labeled leukocytes, J. Nucl. Med. 24 (1) (1983) 39-44.
7. 99mTc-hexamethylpropyleneamineoxime for labeling leukocytes and imaging inflammation, Lancet 2 (1986) 946-949.
8. 111In-labeled non-specific polyclonal IgG, Semin. Nucl. Med. 18 (1998) 335-344.
9. J.T. Locher, K. Seybold, R.Y. Andres, A. Schubiger, Imaging of inflammatory lesions after injection of radioiodinated monoclonal antigranulocyte antibodies, Nucl. Med. Commun. 7 (1986) 659-670.
10. R. Snyderman, R.J. Uhing, Chemoattractant stimulus-response coupling, in: J.I. Gallin, I.M. Goldstein, R. Snyderman (Eds.), Inflammation: Basic Principles and Clinical Correlates, 2nd ed, Raven Press, New York, 1992, p. 421.
11. 99mTc-hexamethylpropyleneamineoxime for labeling leukocytes and imaging inflammation, Lancet 2 (1986) 946-949.
12. S.C. Srivastava, L.R. Chervu, Radionuclide labeled red blood cells: Current status and future prospects, Semin. Nucl. Med. 14 (2) (1984) 68-82.
13. H. Sinn, P. Georgi, J. Clorious, W. Maier-Borst, Die markierung von Erythrozyten mit radioaktiven Indiumisotopen, Nucl. Med. (Stuttgart) 13 (1974) 180.
14. J.G. McAfee, M.L. Thakur, Survey of radioactive agents for in vitro labelling of phagocytic leukocytes. I. Soluble agents, J. Nucl. Med. 17 (1976) 480-487.
15. J.G. McAfee, M.L. Thakur, Survey of radioactive agents for in vitro labelling of phagocytic leukocytes. II. Particles, J. Nucl. Med. 17 (1976) 488-492.
16. M.J. Welch, M.L. Thakur, R.E. Coleman, M. Patel, B.A. Siegal, Gallium-68 labeled red cells and platelets: new agents for positron tomography, J. Nucl. Med. 18 (1977) 558-562.
17. J.G. McAfee, G. Subramanian, G. Gagne, Technique of leukocyte harvesting and labeling: problems and pitfalls, Semin. Nucl. Med. 14 (2) (1984) 83.
18. M.L. Thakur, C.L. Seifert, M.T. Madsen, S.M. McKenny, A.G. Desai, C.H. Park, Neutrophil labeling: problems and pitfalls, Semin. Nucl. Med. 14 (2) (1984) 107.
19. H.J. Danpure, S. Osman, Cell labelling and cell damage with indium-Ill acetylacetone: an alternative to indium-111 oxine, Br. J. Radiol. 54 (1981) 597-601.
20. M.K. Dewanjee, S.A. Rao, P. Didisheim, Indium-111-tropolone, a new high affinity platelet label: preparation and evaluation of labeling parameters, J. Nucl. Med. 22 (1981) 981-987.
21. H.J. Danpure, S. Osman, F. Brady, The labeling of blood cells in plasma with In-111-tropolonate, Br. J. Radiol. 55 (1982) 247-249.
22. A.M. Peters, S.H. Saverymuttu, H.J. Reavy, H.J. Danpure, S. Osman, J.P. Lavender, Imaging inflammation with In-111-tropolonate labelled leukocytes, J. Nucl. Med. 24 (1983) 39-44.
23. K.P. Gunter, J.N. Lukens, J.A. Clanton, R.L. Janco, D. English, Neutrophil labeling with Indium-111: tropolone vs. oxine, Radiology 149 (1983) 563-566.
24. M.L. Thakur, S.M. McKenney, C.H. Park, Evaluation of In-111-2-mercaptopyridine-N-oxide for labelling leukocytes in plasma: a kit preparation, J.Nucl Med. 26 (1985) 518-523.
25. 99mTc-labeled leukocytes in dogs and the effects of an abscess, Biomedicine 32 (1980) 133-139.
26. H.J. Schroth, E. Oberhausen, R. Berberich, Cell labeling with colloidal substances in whole blood, Eur. J. Nucl. Med. 6 (1981) 469-472.
27. P.J. Ell, J.M.L. Hocknell, P.H. Jarrit, I. Cullum, D. Lui, A Tc-99m labelled radiotracer for the investigation of cerebral vascular disease, Nucl. Med. Commun. 6 (1985) 437-441.
28. R.A. Allan, G.E. Sladen, S. Bassingham, C. Lazarus, S.E.M. Clarke, I. Fogelman, Comparison of simultaneous Tc-99m HMPAO and In-111 oxine labelled white cell scans in the assessment of inflammatory bowel disease, Eur. J. Nucl. Med. 20 (1993) 195-200.
29. T.J. Mountford, A.G. Kettle, M.J. O'Doherty, A.J. Coakley, Comparison of Tc-99m HMPAO leukocytes with In-111 oxine for localising intra-abdominal sepsis, J. Nucl. Med. 31 (1990) 311-315.
30. J.M. Lange, C.A. Boucher, C.E. Hollak, E.H. Wiltink, P. Reiss, E.A. vanRoyen, M. Roos, S.A. Danner, J. Goudsmit, Failure of zidovudine prophylaxis after accidental exposure to HIV-1, N. Engl. J. Med. 322 (1990) 1375-1377.
31. J. Rojas-Burke, Health officials reacting to infection mishaps, J. Nucl. Med. 33 (1992) 13N-27N.
32. R.H. Rubin, L.S. Young, W.P. Hansen, M. Nedelman, R. Wilkinson, M.J. Nelles, R. Callahan, B.A. Khaw, H.W. Strauss, Specific and non-specific imaging of localized Fisher immunotype I Pseudomonas aeruginosa infection with radiolabeled monoclonal antibody, J. Nucl. Med. 29 (1988) 651-656.
33. 111In-labeled non-specific polyclonal IgG, Semin. Nucl. Med. 18 (1988) 335-344.
34. R.H. Rubin, A.J. Fischman, M. Nedelman, R. Wilkinson, R.J. Callahan, B.A. Khaw, W.P. Hansen, P.B. Kramer, H.W. Strauss, Radiolabeled non-specific polyclonal human immunoglobulin in the detection of focal inflammation by scintigraphy: comparison with Ga-67-citrate and Tc-99m-labeled albumin, J. Nucl. Med. 30 (1989) 385-389.
35. 111In-labeled nonspecific immunoglobulin scanning in the detection of focal infection, N. Engl. J. Med. 321 (1989) 935-940.
36. A.J. Fischman, R.H. Rubin, J.A. White, E. Locke, R.A. Wilkinson, M. Nedelman, R.J. Callahan, B.A. Khaw, H.W Strauss, Localization of Fc and Fab fragments of non-specific polyclonal IgG at focal sites of infection, J. Nucl. Med. 31 (1990) 1199-1205.
37. E.M. Morrell, R.G. Tompkins, A.J. Fischman, H.W. Strauss, R.H. Rubin, R.A. Wilkinson, M.Y. Yarmush, An autoradiographic method for quantitation of radiolabeled proteins in tissue using indiun-111, J. Nucl. Med. 30 (1989) 1538-1545.
38. A.J. Fischman, A.J. Fucello, J.L. Pellegrino-Gensey, J. Geltofsky, M.L. Yarmush, R.H. Rubin, H.W. Strauss, Effect of carbohydrate modification on the localization of human polyclonal IgG at focal sites of bacterial infection, J. Nucl. Med. 33 (1992) 1378-1382.
39. M. Uweid, H.W. Strauss, H. Yaoito, R.H. Rubin, A.J. Fischman, Accumulation of immunoglobulin G at focal sites of infection, Eur. J. Nucl. Med. 19 (1992) 159-165.
40. D.J. Hnatowich, G. Mardirossian, M. Rusckowski, M. Fogarasi, F. Virzi, P. Winnard, Directly and indirectly technetium-99m-labeled antibodies: a comparison of in vitro and in vivo properties, J. Nucl. Med. 34 (1993) 109-119.
41. 99mTc labeled polyclonal IgGs, in: International Symposium of Scintigraphic Detection of Infectious Disease, Nijmegen, Netherlands, 1992.
42. M.J. Abrams, M. Juweid, C.I. ten Kate, D.A. Schwartz, M.M. Hauser, F.E. Gaul, A.J. Fucello, R.H. Rubin, H.W. Strauss, A.J. Fischman, Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection of rats, J. Nucl. Med. 31 (1990) 2022-2028.
43. 99mTc J, Nucl. Med. All. Sci. 33 (1989) 286.
44. 111In labeled white blood cells at sites of acute bacterial infection in rabbits, J. Nucl. Med. 34 (1993) 1975-1979.
45. 99mTc- labeled human polyclonal IgG, Int. J. Nucl. Med. Biol. 21 (1) (1994) 111-116.
46. 99m polyclonal human IgG, J. Nucl. Med. 32 (1991) 1099.
47. R. Weissleder, A.S. Lee, A.J. Fischman, P. Reimer, T. Shen, R. Wilkinson, R.J. Callahan, T.J. Brady, MR antibody imaging: polyclonal human IgG labeled with polymeric iron oxide particles, Radiology 181 (1991) 245-249.
48. D. Pressman, E.D. Day, M. Blau, The use of paired labeling in the determination of tumor localizing antibodies, Cancer Res. 17 (1957) 845-850.
49. G. Kohler, C. Milstein, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature 256 (1975) 495-497.
50. S. VonKleist, G. Chavanel, P. Burtin, Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen, Proc. Natl. Acad. Sci. USA 69 (1972) 2492-2494.
51. P. Burtin, P.C. Quan, M.C. Sabine, Non-specific cross-reactive antigen as a marker for human polymorphs, macrophages and monocytes, Nature 255 (1975) 714-716.
52. F. Buchegger, M. Schreyer, S. Carrel, J.P. Mach, Monoclonal antibodies identify a CEA crossreacting antigen of 95kD(NCA-95) distinct in antigenicity and tissue distribution from the previously described NCA of 55kD, Int. J. Cancer 33 (1984) 643-649.
53. K. Joseph, H. Hoffken, K. Bosslet, H.U. Schorlemmer, In vivo labelling of granulocytes with Tc-99m-anti-NCA monoclonal antibodies for imaging inflammation, Eur. J. Nucl. Med. 14 (1988) 367-373.
54. A. Schubiger, P.H. Hasler, I. Novak-Hofer, P. Blauenstein, Assessment of the binding properties of granuloszint, Eur. J. Nucl. Med. 15 (1989) 605-608.
55. A. Steinstrasser, R. Berberich, L. Kuhlman, S. Zabori, A. Schwartz, Binding des monoklonalen Antikropers BW250/ 183 an menschliche Granulozyten, Nukl. Med. 31 (1992) 57-63.
56. K. Bosslet, A. Stewinstrasser, A. Schwartz, Generation and functional characteristics of the granulocyte selective monoclonal antibody BW 250/183, Nukl. Med. 28 (1989) 148-159.
57. R.Y. Andres, A. Schubinger, L. Tiefenauer, K. Seybold, J.T. Locher, J.P. Mach, F. Buchegger, Immunoscintigraphic localization of inflammatory lesions, concept radiolabeling and in vitro testing of a granulocyte specific antibody, Eur. J. Nucl. Med. 13 (1988) 582-586.
58. A. Schwartz, A. Steinstrasser, A novel approach to Tc-99m-labeled monoclonal antibodies, J. Nucl. Med. 28 (1987) 721.
59. W. Becker, U. Borst, W. Fischback, B. Pasurka, R. Schafer, W. Borner, Kinetic data of in-vivo labeled granulocytes in humans with a murine Tc-99m-labelled monoclonal antibody, Eur. J. Nucl. Med. 15 (7) (1989) 361-366.
60. J. Sciuk, C. Puskas, B. Greitemann, O. Schober, White blood cell scintigraphy with monoclonal antibodies in the study of the infected endoprosthesis, Eur. J. Nucl. Med. 19 (7) (1992) 497-502.
61. P. Reuland, K.-H. Winker, Th. Heuchert, P. Ruck, W. Muller-Schauenburg, Detection of infection in postoperative orthopedic patients with technetium-99m labeled monoclonal antibodies against granulocytes, J. Nucl. Med. 32 (1991) 2209-2214.
62. W. Becker, A. Saptogino, F. Wolf, The single late Tc-99m granulocyte antibody scan in inflammatory diseases, Nucl. Med. Commun. 13 (1992) 186-192.
63. W. Becker, W. Fleig, J. Marienhagen, Diagnostiche Bedeutung der intestinalen Aktivitate bei der Immunszintigraphic mit Tc-99m-NCA-95-Antikorpern, Nukl. Med. 229 (1990) 47-48.
64. M. Cordes, W. Hepp, R. Langer, J. Pannhorst, J. Hierholzer, R. Felix, Vascular graft infection, detection by 1-123 labeled antigranulocyte antibody (anti-NCA-95), Nucl. Med. 30 (1991) 173-177.
65. R.O. Dillman, J.C. Beaureguard, R.E. Sobol, I. Royston, R.M. Bartholomew, P.S. Hagan, S.E. Halpern, Lack of radioimmunodetection and complications associated with monoclonal anticarcinoembryonic antigen antibody cross reactivity with an antigen on circulating cells, Cancer Res. 44 (1984) 2213-2218.
66. W. Becker, U. Lauer, J. Marienhagen, D.M. Goldenberg, F. Wolf, Comparison of Tc-99m-antigranulocyte (NCA-95) Fab′-fragments and scintigraphy with In-111-oxin/Tc-99m-HMPAO-labeled leukocytes in infectious disease, J. Nucl. Med. 33 (1992) 903.
67. 67Ga citrate, J. Nucl. Med. 10 (1969) 103-105.
68. R.L. Littenberg, R.M. Taketa, N.P. Alazraki, S.E. Halpern, W.L. Ashburn, Gallium-67 for localization of septic lesions, Ann. Intern. Med. 79 (3) (1973) 403-406.
69. S.M. Moerlein, M.J. Welch, The chemistry of gallium and indium as related to radiopharmaceutical production, Int. J. Nucl. Med. Biol. 8 (1981) 277-282.
70. M.D. Maines, A. Kapas, Metals as regulators of heme metabolism, Science 198 (1977) 1215-1221.
71. R. Bennet, T. Kokocinski, Lactoferrin content of peripheral blood cells, Br. J. Haematol. 39 (1978) 509-521.
72. P. Wang-Iversen, K.B. Pryzwansky, J.K. Spitznagel, M.H. Cooney, Bacterial capacity of phorbol myristate acetate treated human polymorphonuclear leukocytes, Infect. Immun. 22 (1974) 945-955.
73. J.L. Van Snick, B. Markowetz, P.L. Masson, The ingestion of human lactoferrin by mouse peritoneal macrophages and the transfer of its iron into ferritin, J. Exp. Med. 146 (1977) 817-827.
74. J.B. Nielands, Sidersphores, biochemical ecology and mechanisms of iron transport in enterobacteria, in: K.N. Raymond (Ed.), Bioinorganic Chemistry II, Advanced Chemistry Series, Vol. 162, American Chemical Society, Washington, DC, 1977, pp. 3-32.
75. D.S. Fineman, C.J. Palestro, C.K. Kim, L.B. Needle, S. Vallabhajsula, R.W. Solomon, S.J. Goldsmith, Detection of abnormalities in febrile AIDS patients with In-111-labeled leukocytes and Ga-67 scintigraphy, Radiology 170 (1989) 677-680.
76. C.J. van der Laken, O.C. Boerman, W.J. Oyen, M.T. van de Ven, R.A. Claessens, J.W. van der Meer, F.H. Corstens, Specific targeting of infectious foci with radioiodinated human recombinant interleukin-1 in an experimental model, Eur. J. Nucl. Med. 22 (11) (1995) 1249-1255.
77. C.J. van der Laken, O.C. Boerman, W.J. Oyen, M.T. van de Ven, J.W. van der Meer, F.H. Corstens, Imaging of infection in rabbits with radioiodinated interleukin-1 (alpha and beta), its receptor antagonist and a chemotactic peptide, a comparative study, Eur. J. Nucl. Med. 25 (4) (1998) 347-352.
78. M. Baggiolini, A. Waiz, S.L. Kunkel, Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils, J. Clin. Invest. 84 (1989) 1045-1049.
79. T.F. Deuel, R.M. Senior, D. Chang, G.L. Griffin, R.L. Heinrikson, E.T. Kaiser, Platelet factor 4 is chemoattractant for neutrophils and monocytes, Proc. Natl. Acad. Sci. USA 78 (1981) 4584-4587.
80. H.J. Showell, R.J. Freer, S.H. Zigmond, E. Schiffman, S. Aswanikumar, B. Corcoran, E.L. Becker, The structural relations of synthetic peptides as chemotactic factors and inducers of lysosomal enzyme secretion for neutrophils, J. Exp. Med. 143 (1976) 1154-1169.
81. E. Schiffman, B.A. Corcoran, S.M. Wahl, Formylmethionyl peptides as chemoattractants for leukocytes, Proc. Natl. Acad. Sci. USA 72 (1975) 1059-1062.
82. L.T. Williams, R. Snyderman, M.C. Pike, R.J. Lefkowitz, Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes, Proc. Natl. Acad. Sci. USA 74 (1977) 1204-1208.
83. B. Goins, R. Klipper, A.S. Rudolph, R.O. Cliff, R. Blumhardt, W.T. Phillips, Biodistribution and imaging studies of technetium-99m-labeled liposomes in rats with focal infection, J. Nucl. Med. 34 (12) (1993) 2160-2168.
84. O.C. Boerman, G. Storm, W.J. Oyen, L. van Bloois, J.W. van der Meer, R.A. Claessens, D.J. Crommelin, F.H. Corstens, Sterically stabilized liposomes labeled with indium-111 to image focal infection, J. Nucl. Med. 36 (9) (1995) 1639-1644.
85. R. Synderman, M.W. Verghese, Leukocyte activation by chemoattractant receptors: roles of a guanine nucleotide regulatory protein and polyphosphoinositide metabolism, Rev. Infect. Dis. 9 (1987) S562-S569.
86. M.P. Fletcher, B.E. Seligman, J.I. Gallin, Correlation of human neutrophil secretion: chemoattractant receptor mobilization and enhanced functional capacity, J. Immunol. 128 (1988) 941-948.
87. 125I-chemotactic peptide by human neutrophils, J. Biol. Chem. 10 (1979) 700-710.
88. H.J. Showell, R.J. Freer, S.H. Zigmond, E. Schiffman, S. Aswanikumar, B. Corcoran, E.L. Becker, The structural relations of synthetic peptides as chemotactic factors and inducers of lysosomal enzyme secretion for neutrophils, J. Exp. Med. 143 (1976) 1154-1169.
89. E. Schiffmann, B.A. Corcoran, S.M. Wahl, Formylmethionyl peptides as chemoattractants for leukocytes, Proc. Natl. Acad. Sci. USA 72 (1975) 1059-1062.
90. J. Niedel, J. Davis, P. Cuatrecasas, Covalent affinity labeling of the formyl peptide chemotactic receptor, J. Biol. Chem. 255 (1980) 7063-7066.
91. S.S. Zogbhi, M.L. Thakur, A. Gottschalk, A potential radioactive agent for labeling of human neutrophils, J. Nucl. Med. 22 (Abstr.) (1981) 32.
92. M.S. Jiang, E.G. Corley, H.N. Wagner, M.F. Tsan, Localization of abscess with an iodinated synthetic chemotactic peptide, J. Nukl. Med. 21 (1982) 110-113.
93. J.T. O'Flaherty, H.J. Showell, P.A. Ward, Neutropenia induced by systemic infection of chemotactic factors, J. Immunol. 118 (1977) 1586-1589.
94. A.J. Fischman, M.C. Pike, D. Kroon, A.J. Fucello Rex, D. Rexinger, C. ten Kate, R. Wilkinson, R.H. Rubin, H.W. Strauss, Imaging of focal sites of bacterial infection in rats with In-labeled chemotactic peptide analogs, J. Nucl. Med. 32 (1991) 483-491.
95. J.W. Babich, H. Solomon, M.C. Pike, D. Kroon, W. Graham, M.J. Abrams, R.G. Tompkins, R.H. Rubin, A.J. Fischman, Technetium-99m-labeled-hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection, J. Nucl. Med. 34 (1993) 1964-1974.
96. M.J. Abrams, M. Juweid, C. ten Kate, D.A. Schwartz, M.M. Hauser, F.E. Gaul, A.J. Fucello, R.H. Rubin, H.W. Strauss, A.J. Fischman, Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection of rats, J. Nucl. Med. 31 (1990) 2022-2028.
97. J.W. Babich, W. Graham, S. Barrow, S. Dragotakes, R.G. Tompkins, R.H. Rubin, A.J. Fischman, Technetium-99m-labeled chemotactic peptides: comparison with indium-111-labeled white blood cells for localizing acute bacterial infections in the rabbit, J. Nucl. Med. 34 (1993) 2176-2181.
98. J.W. Babich, W. Graham, S. Barrow, A.J. Fischman, Comparison of the infection imaging properties of a 99mTc labeled chemotactic peptide with 111In IgG (abstract), J. Nucl. Med. 35 (1994) 174.
99. J.W. Babich, R.G. Tompkins, W. Graham, S. Barrow, A.J. Fischman, Localization of radiolabeled chemotactic peptide at sites of Escherichia coli infection in rabbits: Evidence for a receptor-specific mechanism, J. Nucl. Med. 38 (1997) 1316-1322.
100. C.J. van der Laken, O.C. Boerman, W.J. Oyen, M.T. van de Yen, D.S. Edwards, J.A. Barrett, J.W. van der Meer, F.H. Corstens, Technetium-99m-labeled chemotactic peptides in acute infection and sterile inflammation, J. Nucl. Med. 38 (8) (1997) 1310-1315.
101. A.J. Fischman, D. Rauh, H. Solomon, J.W. Babich, R.G. Tompkins, D. Kroon, H.W. Strauss, R.H. Rubin, In vivo bioactivity and biodistribution of chemotactic peptide analogs in nonhuman primates, J. Nucl. Med. 34 (1993) 2130-2134.
102. A. Pollak, A.E. Goodbody, J.R. Ballinger, G.S. Duncan, L.L. Tran, R. Dunn-Dufault, K. Meghji, F. Lau, T.W. Andrey, I. Boxen, M. Sumner-Smith, Imaging inflammation with 99Tcm-labeled chemotactic peptides, analogues with reduced neutropenia, Nucl. Med. Commun. 17 (2) (1996) 132-139.
103. K.E. Baidoo, U. Scheffel, M. Stathis, P. Finley, S.Z. Lever, Y. Zhan, H.N. Wagner, High-affinity no-carrier-added 99mTc-labeled chemotactic peptides for studies of inflammation in vivo, Bioconjug. Chem. 9 (2) (1998) 208-217.